Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells

被引:34
|
作者
Blume, Lawrence C. [1 ]
Eldeeb, Khalil [1 ]
Bass, Caroline E. [1 ]
Selley, Dana E. [2 ]
Howlett, Allyn C. [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
CB1; receptor; CRIP1a; cAMP; ERK1/2; G protein; Endocannabinoid; ADENYLATE-CYCLASE; TYROSINE KINASES; INVERSE AGONIST; BRAIN; TRANSDUCTION; PHARMACOLOGY; ASSOCIATION; ENDOCYTOSIS; INHIBITION; ACTIVATION;
D O I
10.1016/j.cellsig.2014.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CBI cannabinoid receptors (CB1R) are one of the most abundantly expressed G protein coupled receptors (GPCR) in the CNS and regulate diverse neuronal functions. The identification of GPCR interacting proteins has provided additional insight into the fine-tuning and regulation of numerous GPCRs. The cannabinoid receptor interacting protein 1a (CRIP1a) binds to the distal carboxy terminus of CB1R, and has been shown to alter CB1R-mediated neuronal function [1]. The mechanisms by which CRIP1a regulates CB1R activity have not yet been identified; therefore the focus of this investigation is to examine the cellular effects of CRIP1a on CB1R signaling using neuronal N18TG2 cells stably transfected with CRIP1a over-expressing and CRIP1a knockdown constructs. Modulation of endogenous CRIP1 a expression did not alter total levels of CB1R, ERK, or forskolin-activated adenylyl cyclase activity. When compared to WT cells, CRIP1a over-expression reduced basal phosphoERK levels, whereas depletion of CRIP1a augmented basal phosphoERK levels. Stimulation of phosphoERK by the CB1R agonists WIN55212-2, CP55940 or methanandamide was unaltered in CRIP1a over-expressing clones compared with WT. However, CRIP1 a knockdown clones exhibited enhanced ERIC phosphorylation efficacy in response to CP55940. In addition, CRIP1a knockdown clones displayed a leftward shift in CP55940-mediated inhibition of forskolin-stimulated cAMP accumulation. CB1R-mediated G(i3) and G(o) activation by CP99540 was attenuated by CRIP1a over-expression, but robustly enhanced in cells depleted of CRIP1a. Conversely, CP55940-mediated and G(i2) activation was significant enhanced in cells over-expressing CRIP1a, but not in cells deficient of CRIP1a. These studies suggest a mechanism by which endogenous levels of CRIP1a modulate CB1R-mediated signal transduction by facilitating a G(i/o) protein subtype preference for G(i1) and G(i2), accompanied by an overall suppression of G-protein-mediated signaling in neuronal cells. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:716 / 726
页数:11
相关论文
共 50 条
  • [1] Cannabinoid Receptor Interacting Protein (CRIP1a) attenuates CB1 signalling
    Hardt, Tricia Ann
    Elphick, Maurice
    Lewis, Deborah L.
    Selley, Dana E.
    FASEB JOURNAL, 2009, 23
  • [2] Cannabinoid Receptor Interacting Protein (CRIP1a) affects CB1 signaling
    Hardt, Tricia Ann
    Selley, Dana E.
    Elphick, Maurice R.
    Lewis, Deborah
    He, Hengjun
    Hernandez, Jerry
    FASEB JOURNAL, 2008, 22
  • [3] Cannabinoid Receptor Interacting Protein 1a (CRIP1a) regulates CB1 signaling and transcriptional activity
    Blume, Lawrence Christopher
    Bass, Caroline E.
    Dalton, George D.
    Selley, Dana E.
    Howlett, Allyn C.
    FASEB JOURNAL, 2012, 26
  • [4] Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus
    Stephan Guggenhuber
    Alan Alpar
    Rongqing Chen
    Nina Schmitz
    Melanie Wickert
    Tobias Mattheus
    Anne E. Harasta
    Martin Purrio
    Nadine Kaiser
    Maurice R. Elphick
    Krisztina Monory
    Werner Kilb
    Heiko J. Luhmann
    Tibor Harkany
    Beat Lutz
    Matthias Klugmann
    Brain Structure and Function, 2016, 221 : 2061 - 2074
  • [5] Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus
    Guggenhuber, Stephan
    Alpar, Alan
    Chen, Rongqing
    Schmitz, Nina
    Wickert, Melanie
    Mattheus, Tobias
    Harasta, Anne E.
    Purrio, Martin
    Kaiser, Nadine
    Elphick, Maurice R.
    Monory, Krisztina
    Kilb, Werner
    Luhmann, Heiko J.
    Harkany, Tibor
    Lutz, Beat
    Klugmann, Matthias
    BRAIN STRUCTURE & FUNCTION, 2016, 221 (04): : 2061 - 2074
  • [6] Cannabinoid Receptor Interacting Protein 1a (CRIP1a) Regulates CB1 Receptor Trafficking
    Blume, Lawrence C.
    Dalton, George D.
    Selley, Dana E.
    Howlett, Allyn C.
    FASEB JOURNAL, 2013, 27
  • [7] Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
    Booth, William T.
    Walker, Noah B.
    Lowther, W. Todd
    Howlett, Allyn C.
    MOLECULES, 2019, 24 (20):
  • [8] Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease
    Oliver, Emily E.
    Hughes, Erin K.
    Puckett, Meaghan K.
    Chen, Rong
    Lowther, W. Todd
    Howlett, Allyn C.
    BIOMOLECULES, 2020, 10 (12) : 1 - 22
  • [9] Structure and Function of Cannabinoid Receptor Interacting Protein 1a (CRIP1a)
    Hughes, Erin
    Booth, William
    Clodfelter, Jill
    Leone-Kabler, Sandra
    Howlett, Allyn
    Lowther, W.
    FASEB JOURNAL, 2021, 35
  • [10] Functional characterization of cannabinoid receptor-interacting protein CRIP1a
    Selley, Dana E.
    Jacob, Joanna C.
    Smith, Tricia H.
    Blume, Lawrence C.
    Shim, Hoon
    Straiker, Alex
    Mackie, Ken
    Howlett, Allyn C.
    Sim-Selley, Laura J.
    Chen, Ching-Kang
    FASEB JOURNAL, 2013, 27